CLINICAL_TRIALS trial_result · 2017-06-14

Clinical Trial Update: FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer [NA]

Clinical trial investigating FDG PET and DCE-MRI to predict treatment response in breast cancer patients has been terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Washington | Conditions: Male Breast Cancer, Stage II Breast Cancer | NA | Status: TERMINATED | Results posted: 2017-06-14